Fulgent Genetics (MEX:FLGT) 5-Year ROIIC % : -9.44% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Fulgent Genetics's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -9.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Fulgent Genetics's 5-Year ROIIC % or its related term are showing as below:

MEX:FLGT's 5-Year ROIIC % is ranked worse than
57.62% of 210 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.89 vs MEX:FLGT: -9.44

Fulgent Genetics 5-Year ROIIC % Historical Data

The historical data trend for Fulgent Genetics's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics 5-Year ROIIC % Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

5-Year ROIIC %

Get a 7-Day Free Trial

1.09

72.40

66.24

18.01

-9.44

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
5-Year ROIIC %	Get a 7-Day Free Trial															-	-	-	-9.44	-

Competitive Comparison of Fulgent Genetics's 5-Year ROIIC %

For the Diagnostics & Research subindustry, Fulgent Genetics's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's 5-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's 5-Year ROIIC % falls into.

Fulgent Genetics 5-Year ROIIC % Calculation

Fulgent Genetics's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

5-Year ROIIC %	=	5-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	5-Year Incremental Invested Capital^**
	=	( -1286.5113016 (Dec. 2023) - -100.3254822 (Dec. 2018) )	/	( 13053.774 (Dec. 2023) - 398.551 (Dec. 2018) )
	=	-1186.1858194	/	12655.223
	=	-9.37%^***

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Fulgent Genetics (MEX:FLGT) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Fulgent Genetics 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » 5-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.